These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8255496

  • 21. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
    Haupt WF, Rosenow F, van der Ven C, Borberg H, Pawlik G.
    Ther Apher; 1997 Feb; 1(1):55-7. PubMed ID: 10225782
    [Abstract] [Full Text] [Related]

  • 22. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC, Annane D, Chevret S, Chillet P, Gajdos P.
    Presse Med; 1996 Oct 19; 25(31):1516-22. PubMed ID: 8958883
    [Abstract] [Full Text] [Related]

  • 23. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
    Haupt WF, Rosenow F, van der Ven C, Borberg H, Pawlik G.
    J Neurol Sci; 1996 May 19; 137(2):145-9. PubMed ID: 8782169
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA, Raphaël JC, Swan AV, van Doorn PA.
    Cochrane Database Syst Rev; 2001 May 19; (2):CD002063. PubMed ID: 11406030
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of Guillain-Barré syndrome in adults: role of plasma exchange].
    Raphael JC, Chevret S, Auriant I, Sharshar T, Bouget J, Bolgert F.
    Rev Med Interne; 1998 Jan 19; 19(1):60-8. PubMed ID: 9775118
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M, Assanta N, Chiaravalloti G, Rocopou C, Caiulo VA.
    Minerva Pediatr; 1992 May 19; 44(5):237-40. PubMed ID: 1620076
    [Abstract] [Full Text] [Related]

  • 36. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA.
    J Peripher Nerv Syst; 2005 Jun 19; 10(2):113-27. PubMed ID: 15958124
    [Abstract] [Full Text] [Related]

  • 37. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K, Hattori N, Sobue G.
    Nihon Naika Gakkai Zasshi; 2002 Aug 10; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract] [Full Text] [Related]

  • 38. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA, Raphaël JC, Swan AV, van Doorn PA.
    Cochrane Database Syst Rev; 2006 Jan 25; (1):CD002063. PubMed ID: 16437439
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.